As well as CDH1 promoter silencing, DNMT1 is also responsible for the methylation of fructose-1,6-biphosphatase (FBP1) promoter, thus contributing to metabolic reprogramming by enhancing glycolytic flux, macromolecule biosynthesis, and ATP production for supporting enhanced cancer cell proliferation [86]. This evidence concerns the gene DNMT1 and cancer.